Medicare Prescription Drug Plans

Search documents
CENTENE CORPORATION REPORTS SECOND QUARTER 2025 RESULTS
Prnewswire· 2025-07-25 10:00
-- Diluted Loss Per Share of $(0.51); Adjusted Diluted Loss Per Share of $(0.16) --ST. LOUIS, July 25, 2025 /PRNewswire/ -- Centene Corporation (NYSE: CNC) (the Company) announced today its financial results for the second quarter ended June 30, 2025. In summary, the 2025 second quarter results were as follows: Total revenues (in millions) $ 48,742 Premium and service revenues (in millions) $ 42,467 Health benefits ratio 93.0 % SG&A expense ratio 7.1 % Adjus ...